• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在亚洲人群中,近视性光折射性角膜切削术后的屈光结果、角膜混浊和内皮细胞丢失:新加坡武装部队的经验。

Refractive outcomes, corneal haze and endothelial cell loss after myopic photorefractive keratectomy in an Asian population: The Singapore Armed Forces' experience.

机构信息

Vision Performance Centre, Military Medicine Institute, Singapore Armed Forces, Singapore, Singapore.

National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.

出版信息

Clin Exp Ophthalmol. 2020 Jul;48(5):558-568. doi: 10.1111/ceo.13759. Epub 2020 Apr 22.

DOI:10.1111/ceo.13759
PMID:32315500
Abstract

IMPORTANCE

This study reports outcomes of myopic photorefractive keratectomy (PRK) in a mainly ethnic Chinese population in Singapore.

BACKGROUND

To assess the incidence and associations of corneal haze and endothelial cell count (ECC) loss up to 12 months after PRK.

DESIGN

This was a retrospective case series conducted in a tertiary eye centre.

PARTICIPANTS

A total of 158 patients (309 eyes) with a mean age of 22.1 ± 3.4 years were included. The majority was Chinese (97.4%) and male (97.4%). Mean preoperative spherical equivalent was -3.33 ± 1.15 D.

METHODS

Eyes were categorized based on postoperative haze severity. A multivariate analysis adjusting for age and use of intraoperative mitomycin-C (MMC), preoperative sphere and cylinder was performed.

MAIN OUTCOME MEASURES

Refractive outcomes and corneal haze 3 and 12 months after PRK were assessed. ECC measurements were obtained before PRK and at variable periods postoperatively.

RESULTS

At 12 months, overall efficacy index was 0.98, and safety index was 1.09. Eight (2.5%) eyes underwent enhancement surgery. An analysis was performed on 295 eyes that did not undergo enhancement and had complete clinical data, which demonstrated a decrease in the incidence of haze from 38.2% at 3 months to 9.3% at 12 months. Higher myopia was associated with increased haze severity at 3 months (OR, 1.36; P = .005). Higher astigmatism was associated with increased haze severity at 3 (OR, 1.65; P = .018) and 12 months (OR, 2.32; P = .015). Intraoperative MMC was not associated with haze severity or ECC loss.

CONCLUSIONS AND RELEVANCE

Myopia and astigmatism were associated with increased corneal haze severity. Intraoperative MMC did not accelerate ECC loss. Overall, PRK is effective, predictable and safe in Asian eyes.

摘要

重要性

本研究报告了在新加坡主要是华人群体中进行的近视光折射性角膜切削术(PRK)的结果。

背景

评估 PRK 术后 12 个月内角膜混浊和内皮细胞计数(ECC)丧失的发生率和相关性。

设计

这是一项在三级眼科中心进行的回顾性病例系列研究。

参与者

共纳入 158 名(309 只眼)平均年龄为 22.1±3.4 岁的患者。大多数为中国人(97.4%)和男性(97.4%)。平均术前球镜等效值为-3.33±1.15D。

方法

根据术后混浊严重程度对眼睛进行分类。进行了一项多变量分析,调整了年龄、术中丝裂霉素 C(MMC)的使用、术前球镜和柱镜。

主要观察指标

评估 PRK 后 3 个月和 12 个月的屈光结果和角膜混浊。在 PRK 之前和术后不同时间测量 ECC。

结果

12 个月时,总体疗效指数为 0.98,安全指数为 1.09。8 只(2.5%)眼行增强手术。对未行增强且具有完整临床资料的 295 只眼进行了分析,结果显示 3 个月时混浊发生率从 38.2%下降至 12 个月时的 9.3%。高度近视与 3 个月时混浊程度加重相关(OR,1.36;P=0.005)。较高的散光与 3 个月(OR,1.65;P=0.018)和 12 个月(OR,2.32;P=0.015)时混浊程度加重相关。术中使用丝裂霉素 C与混浊严重程度或 ECC 丧失无关。

结论和相关性

近视和散光与角膜混浊程度加重相关。术中使用丝裂霉素 C不会加速 ECC 丧失。总体而言,PRK 在亚洲人群中是有效、可预测且安全的。

相似文献

1
Refractive outcomes, corneal haze and endothelial cell loss after myopic photorefractive keratectomy in an Asian population: The Singapore Armed Forces' experience.在亚洲人群中,近视性光折射性角膜切削术后的屈光结果、角膜混浊和内皮细胞丢失:新加坡武装部队的经验。
Clin Exp Ophthalmol. 2020 Jul;48(5):558-568. doi: 10.1111/ceo.13759. Epub 2020 Apr 22.
2
Risk factors for early-onset corneal haze after photorefractive keratectomy in an Asian population: Outcomes from the Singapore Armed Forces Corneal Refractive Surgery Programme 2006 to 2013.亚洲人群中准分子激光原位角膜磨镶术后早期角膜混浊的危险因素:2006年至2013年新加坡武装部队角膜屈光手术项目的结果
J Cataract Refract Surg. 2016 May;42(5):710-6. doi: 10.1016/j.jcrs.2016.01.047.
3
Past and present of corneal refractive surgery: a retrospective study of long-term results after photorefractive keratectomy and a prospective study of refractive lenticule extraction.角膜屈光手术的过去和现在:准分子激光角膜切削术长期疗效的回顾性研究和准分子激光透镜切除术的前瞻性研究。
Acta Ophthalmol. 2014 Mar;92 Thesis 2:1-21. doi: 10.1111/aos.12385.
4
Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.丝裂霉素C辅助的准分子激光原位角膜磨镶术后角膜突破型 haze:发生率及危险因素
Cornea. 2017 Aug;36(8):961-966. doi: 10.1097/ICO.0000000000001231.
5
The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.美国陆军表面消融研究:中高度近视的 PRK、MMC-PRK 和 LASEK 的比较。
J Refract Surg. 2014 Apr;30(4):256-64. doi: 10.3928/1081597X-20140320-04.
6
Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.随机剂量反应分析丝裂霉素 C 预防高度近视光折射性角膜切削术后混浊
J Cataract Refract Surg. 2013 Sep;39(9):1358-65. doi: 10.1016/j.jcrs.2013.03.029. Epub 2013 Jul 3.
7
Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.轻度至中度近视患者中使用或不使用丝裂霉素C的单步经上皮光屈光性角膜切削术的比较
J Refract Surg. 2018 Jun 1;34(6):400-407. doi: 10.3928/1081597X-20180402-02.
8
Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy.丝裂霉素-C对屈光性角膜切削术后屈光结果差异的影响。
J Cataract Refract Surg. 2014 Dec;40(12):1980-4. doi: 10.1016/j.jcrs.2014.02.048. Epub 2014 Oct 8.
9
Mitomycin C 0.02 and 0.002% efficacy in preventing haze after photorefractive keratectomy.丝裂霉素C浓度为0.02%和0.002%时在预防准分子激光屈光性角膜切削术后角膜雾状混浊中的疗效。
Int Ophthalmol. 2019 Feb;39(2):341-345. doi: 10.1007/s10792-017-0817-7. Epub 2018 Jan 16.
10
Comparison of single-step transepithelial photorefractive keratectomy and conventional photorefractive keratectomy in low to high myopic eyes.比较低中度近视至高度近视眼角膜经上皮准分子激光角膜切削术和常规准分子激光角膜切削术的疗效。
Indian J Ophthalmol. 2020 May;68(5):755-761. doi: 10.4103/ijo.IJO_1126_19.

引用本文的文献

1
Applications of Mitomycin C in Cornea and External Disease.丝裂霉素 C 在角膜和眼表疾病中的应用。
Turk J Ophthalmol. 2023 Jun 21;53(3):175-182. doi: 10.4274/tjo.galenos.2023.97932.